These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 20634293)

  • 1. CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor.
    Zhao B; Degroot DE; Hayashi A; He G; Denison MS
    Toxicol Sci; 2010 Oct; 117(2):393-403. PubMed ID: 20634293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent binding of ligands to the aryl hydrocarbon receptor.
    Bohonowych JE; Denison MS
    Toxicol Sci; 2007 Jul; 98(1):99-109. PubMed ID: 17431010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide specificity of DNA binding of the aryl hydrocarbon receptor:ARNT complex is unaffected by ligand structure.
    DeGroot DE; Denison MS
    Toxicol Sci; 2014 Jan; 137(1):102-13. PubMed ID: 24136190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing tools for risk assessment in protected species: Relative potencies inferred from competitive binding of halogenated aromatic hydrocarbons to aryl hydrocarbon receptors from beluga (Delphinapterus leucas) and mouse.
    Jensen BA; Reddy CM; Nelson RK; Hahn ME
    Aquat Toxicol; 2010 Nov; 100(3):238-45. PubMed ID: 20728228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds.
    Okey AB; Riddick DS; Harper PA
    Toxicol Lett; 1994 Jan; 70(1):1-22. PubMed ID: 8310450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newspapers and newspaper ink contain agonists for the ah receptor.
    Bohonowych JE; Zhao B; Timme-Laragy A; Jung D; Di Giulio RT; Denison MS
    Toxicol Sci; 2008 Apr; 102(2):278-90. PubMed ID: 18203687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of selective activation of aryl hydrocarbon receptor nongenomic calcium signaling by pyrene.
    Brinchmann BC; Le Ferrec E; Bisson WH; Podechard N; Huitfeldt HS; Gallais I; Sergent O; Holme JA; Lagadic-Gossmann D; Øvrevik J
    Biochem Pharmacol; 2018 Dec; 158():1-12. PubMed ID: 30248327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient suppression of AHR activity in early red seabream embryos does not prevent the disruption of peripheral nerve projection by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Iida M; Bak SM; Murakami Y; Kim EY; Iwata H
    Aquat Toxicol; 2014 Sep; 154():39-47. PubMed ID: 24858342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CH223191-Induced Mitochondrial Dysfunction on Its Aryl Hydrocarbon Receptor Agonistic and Antagonistic Activities.
    Mohammadi-Bardbori A; Omidi M; Arabnezhad MR
    Chem Res Toxicol; 2019 Apr; 32(4):691-697. PubMed ID: 30793600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of diuron and related substituted phenylureas with the Ah receptor pathway.
    Zhao B; Baston DS; Hammock B; Denison MS
    J Biochem Mol Toxicol; 2006; 20(3):103-13. PubMed ID: 16788953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ah receptor-based chemical screening bioassays: application and limitations for the detection of Ah receptor agonists.
    Seidel SD; Li V; Winter GM; Rogers WJ; Martinez EI; Denison MS
    Toxicol Sci; 2000 May; 55(1):107-15. PubMed ID: 10788565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses.
    Wilson CL; Safe S
    Toxicol Pathol; 1998; 26(5):657-71. PubMed ID: 9789953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel CH223191-based antagonists of the aryl hydrocarbon receptor.
    Choi EY; Lee H; Dingle RW; Kim KB; Swanson HI
    Mol Pharmacol; 2012 Jan; 81(1):3-11. PubMed ID: 21967751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a green fluorescent protein-based cell bioassay for the rapid and inexpensive detection and characterization of ah receptor agonists.
    Nagy SR; Sanborn JR; Hammock BD; Denison MS
    Toxicol Sci; 2002 Feb; 65(2):200-10. PubMed ID: 11812924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of aryl hydrocarbon receptor signaling by 6,2',4'-trimethoxyflavone.
    Murray IA; Flaveny CA; DiNatale BC; Chairo CR; Schroeder JC; Kusnadi A; Perdew GH
    J Pharmacol Exp Ther; 2010 Jan; 332(1):135-44. PubMed ID: 19828881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenosides are novel naturally-occurring aryl hydrocarbon receptor ligands.
    Hu Q; He G; Zhao J; Soshilov A; Denison MS; Zhang A; Yin H; Fraccalvieri D; Bonati L; Xie Q; Zhao B
    PLoS One; 2013; 8(6):e66258. PubMed ID: 23776647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of homology models of the AH receptor ligand binding domain: verification of structure-function predictions by site-directed mutagenesis of a nonfunctional receptor.
    Fraccalvieri D; Soshilov AA; Karchner SI; Franks DG; Pandini A; Bonati L; Hahn ME; Denison MS
    Biochemistry; 2013 Jan; 52(4):714-25. PubMed ID: 23286227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common commercial and consumer products contain activators of the aryl hydrocarbon (dioxin) receptor.
    Zhao B; Bohonowych JE; Timme-Laragy A; Jung D; Affatato AA; Rice RH; Di Giulio RT; Denison MS
    PLoS One; 2013; 8(2):e56860. PubMed ID: 23441220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
    Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
    J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation.
    Henry EC; Kende AS; Rucci G; Totleben MJ; Willey JJ; Dertinger SD; Pollenz RS; Jones JP; Gasiewicz TA
    Mol Pharmacol; 1999 Apr; 55(4):716-25. PubMed ID: 10101030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.